Your browser doesn't support javascript.
loading
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3.
Schirwani, Schaida; Albaba, Shadi; Carere, Deanna Alexis; Guillen Sacoto, Maria J; Milan Zamora, Francisca; Si, Yue; Rabin, Rachel; Pappas, John; Renaud, Deborah L; Hauser, Natalie; Reid, Evan; Blanchet, Patricia; Foulds, Nichola; Dixit, Abhijit; Fisher, Richard; Armstrong, Ruth; Isidor, Bertrand; Cogne, Benjamin; Schrier Vergano, Samantha; Demirdas, Serwet; Dykzeul, Natalie; Cohen, Julie S; Grand, Katheryn; Morel, Dayna; Slavotinek, Anne; Albassam, Hessa F; Naik, Swati; Dean, John; Ragge, Nicola; Costa, Cinzia; Tedesco, Maria Giovanna; Harrison, Rachel E; Bouman, Arjan; Palen, Emily; Challman, Thomas D; Willemsen, Marjolein H; Vogt, Julie; Cunniff, Christopher; Bergstrom, Katherine; Walia, Jagdeep S; Bruel, Ange-Line; Kini, Usha; Alkuraya, Fowzan S; Slegesky, Valerie; Meeks, Naomi; Girotto, Paula; Johnson, Diana; Newbury-Ecob, Ruth; Ockeloen, Charlotte W; Prontera, Paolo.
Afiliação
  • Schirwani S; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Albaba S; Academic Unit of Child Health, Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK.
  • Carere DA; Sheffield Diagnostic Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Guillen Sacoto MJ; GeneDx, Inc, Gaithersburg, Maryland, USA.
  • Milan Zamora F; GeneDx, Inc, Gaithersburg, Maryland, USA.
  • Si Y; GeneDx, Inc, Gaithersburg, Maryland, USA.
  • Rabin R; GeneDx, Inc, Gaithersburg, Maryland, USA.
  • Pappas J; Department of Pediatrics, New York University School of Medicine, New York, New York, USA.
  • Renaud DL; Department of Pediatrics, New York University School of Medicine, New York, New York, USA.
  • Hauser N; Division of Child and Adolescent Neurology, Departments of Neurology and Pediatrics, Mayo Clinic, Rochester, Minnesota, USA.
  • Reid E; Department of Pediatrics, Division of Medical Genomics, Inova Health System, Falls Church, Virginia, USA.
  • Blanchet P; Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
  • Foulds N; Département de Génétique Médicale, CHU de Montpellier, Montpellier, France.
  • Dixit A; Wessex Clinical Genetics Services, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Fisher R; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Armstrong R; Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Isidor B; Teesside Genetics Unit, The James Cook University Hospital, Middlesbrough, UK.
  • Cogne B; Departments of Medical Genetics and Paediatric Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Schrier Vergano S; Service de génétique médicale, CHU Nantes, Nantes, France.
  • Demirdas S; Service de génétique médicale, CHU Nantes, Nantes, France.
  • Dykzeul N; Medical Genetics and Metabolism, Children's Hospital of The King's Daughters, Eastern Virginia Medical School, Norfolk, Virginia, USA.
  • Cohen JS; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Grand K; Lucile Packard Children's Hospital, Stanford Children's Health, Palo Alto, California, USA.
  • Morel D; Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Slavotinek A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Albassam HF; Department of Pediatrics, Medical Genetics, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Naik S; University of Miami, Miller School of Medicine, Miami, Florida, USA.
  • Dean J; Department of Pediatrics, Division of Genetics, University of California, San Francisco, San Francisco, California, USA.
  • Ragge N; Department of Pediatrics, Care National Hospital, Riyadh, Saudi Arabia.
  • Costa C; West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Tedesco MG; Clinical Genetics Service, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Harrison RE; West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Bouman A; Neurology Clinic, Department of Medicine, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Palen E; Medical Genetics Unit, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
  • Challman TD; Genetics Unit, "Mauro Baschirotto" Institute for Rare Diseases (B.I.R.D.), Costozza di Longare, Vicenza, Italy.
  • Willemsen MH; Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Vogt J; Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Cunniff C; Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania, USA.
  • Bergstrom K; Autism & Developmental Medicine Institute, Geisinger, Danville, Pennsylvania, USA.
  • Walia JS; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bruel AL; West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Kini U; Division of Medical Genetics, Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.
  • Alkuraya FS; Division of Medical Genetics, Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.
  • Slegesky V; Divsion of Medical Genetics, Departments of Pediatrics, Queen's University, Kingston, Ontario, Canada.
  • Meeks N; UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD Génétique des Anomalies du Développement, FHU-TRANSLAD, Dijon, France.
  • Girotto P; Department of Clinical Genetics, Oxford University Hospitals NHS Trust, Oxford, UK.
  • Johnson D; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Newbury-Ecob R; University of Colorado & Children's Hospital Colorado, Denver, Colorado, USA.
  • Ockeloen CW; Division of Child Neurology, Department of Pediatrics, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • Prontera P; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Am J Med Genet A ; 185(11): 3446-3458, 2021 11.
Article em En | MEDLINE | ID: mdl-34436830
ABSTRACT
The study aimed at widening the clinical and genetic spectrum of ASXL3-related syndrome, a neurodevelopmental disorder, caused by truncating variants in the ASXL3 gene. In this international collaborative study, we have undertaken a detailed clinical and molecular analysis of 45 previously unpublished individuals with ASXL3-related syndrome, as well as a review of all previously published individuals. We have reviewed the rather limited functional characterization of pathogenic variants in ASXL3 and discuss current understanding of the consequences of the different ASXL3 variants. In this comprehensive analysis of ASXL3-related syndrome, we define its natural history and clinical evolution occurring with age. We report familial ASXL3 pathogenic variants, characterize the phenotype in mildly affected individuals and discuss nonpenetrance. We also discuss the role of missense variants in ASXL3. We delineate a variable but consistent phenotype. The most characteristic features are neurodevelopmental delay with consistently limited speech, significant neuro-behavioral issues, hypotonia, and feeding difficulties. Distinctive features include downslanting palpebral fissures, hypertelorism, tubular nose with a prominent nasal bridge, and low-hanging columella. The presented data will inform clinical management of individuals with ASXL3-related syndrome and improve interpretation of new ASXL3 sequence variants.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Deficiências do Desenvolvimento / Predisposição Genética para Doença / Transtornos do Neurodesenvolvimento Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Am J Med Genet A Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Deficiências do Desenvolvimento / Predisposição Genética para Doença / Transtornos do Neurodesenvolvimento Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Am J Med Genet A Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido